Entera Bio Statistics
Total Valuation
Entera Bio has a market cap or net worth of $88.13 million. The enterprise value is $77.48 million.
Important Dates
The last earnings date was Friday, August 8, 2025, after market close.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Entera Bio has 45.66 million shares outstanding. The number of shares has increased by 26.34% in one year.
Current Share Class | 45.66M |
Shares Outstanding | 45.66M |
Shares Change (YoY) | +26.34% |
Shares Change (QoQ) | +7.97% |
Owned by Insiders (%) | 1.97% |
Owned by Institutions (%) | 8.43% |
Float | 28.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 530.91 |
Forward PS | n/a |
PB Ratio | 4.34 |
P/TBV Ratio | 5.11 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 466.72 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.47, with a Debt / Equity ratio of 0.01.
Current Ratio | 10.47 |
Quick Ratio | 5.89 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -82.22% and return on invested capital (ROIC) is -50.28%.
Return on Equity (ROE) | -82.22% |
Return on Assets (ROA) | -44.56% |
Return on Invested Capital (ROIC) | -50.28% |
Return on Capital Employed (ROCE) | -59.41% |
Revenue Per Employee | $8,300 |
Profits Per Employee | -$530,100 |
Employee Count | 20 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Entera Bio has paid $14,000 in taxes.
Income Tax | 14,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.76% in the last 52 weeks. The beta is 1.52, so Entera Bio's price volatility has been higher than the market average.
Beta (5Y) | 1.52 |
52-Week Price Change | +16.76% |
50-Day Moving Average | 1.93 |
200-Day Moving Average | 2.01 |
Relative Strength Index (RSI) | 48.66 |
Average Volume (20 Days) | 64,750 |
Short Selling Information
Short Interest | 37,177 |
Short Previous Month | 55,477 |
Short % of Shares Out | 0.08% |
Short % of Float | 0.13% |
Short Ratio (days to cover) | 0.15 |
Income Statement
In the last 12 months, Entera Bio had revenue of $166,000 and -$10.60 million in losses. Loss per share was -$0.25.
Revenue | 166,000 |
Gross Profit | n/a |
Operating Income | -10.59M |
Pretax Income | -8.51M |
Net Income | -10.60M |
EBITDA | -10.55M |
EBIT | -10.59M |
Loss Per Share | -$0.25 |
Full Income Statement Balance Sheet
The company has $10.86 million in cash and $203,000 in debt, giving a net cash position of $10.66 million or $0.23 per share.
Cash & Cash Equivalents | 10.86M |
Total Debt | 203,000 |
Net Cash | 10.66M |
Net Cash Per Share | $0.23 |
Equity (Book Value) | 17.26M |
Book Value Per Share | 0.44 |
Working Capital | 17.47M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$6.66 million and capital expenditures -$40,000, giving a free cash flow of -$6.70 million.
Operating Cash Flow | -6.66M |
Capital Expenditures | -40,000 |
Free Cash Flow | -6.70M |
FCF Per Share | -$0.15 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -6,378.92% |
Pretax Margin | -6,378.31% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Entera Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -26.34% |
Shareholder Yield | -26.34% |
Earnings Yield | -12.03% |
FCF Yield | -7.60% |
Analyst Forecast
The average price target for Entera Bio is $10.00, which is 418.14% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $10.00 |
Price Target Difference | 418.14% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Entera Bio has an Altman Z-Score of 9.77 and a Piotroski F-Score of 3.
Altman Z-Score | 9.77 |
Piotroski F-Score | 3 |